J Frontier Co (2934.T) Stock Price

J Frontier Co Price

CLOSED
1,980.00
​
Market closed

Over the last 7 years J Frontier Co grew revenue by 20.2% annually, reaching 22.24 B JPY. Earnings per share have grown at 55.9% per year over the last 6 years. For J Frontier Co, the net margin of -1.4% is down versus 3.4% a few years ago.

J Frontier Co stock price

Access this data via the Eulerpool API

J Frontier Co business model & stock analysis

J Frontier Co., Ltd. engages in the sale, manufacture, planning, and development of healthcare products. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 255 full-time employees. The company went IPO on 2021-08-27. The firm operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.

Frequently asked questions about J Frontier Co

Converted at the current exchange rate, the J Frontier Co share trades at 11.17 EUR (1,980.00 JPY).

The revenue of J Frontier Co is 22.24 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of J Frontier Co is -321.31 M JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of J Frontier Co is currently -32.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the J Frontier Co stock.

The price-to-sales ratio (P/S) of J Frontier Co is currently 0.47. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the J Frontier Co stock.

The Eulerpool Quality Score for J Frontier Co is 2/10.

The ISIN of J Frontier Co is JP3386650000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of J Frontier Co is A3DB7Y. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of J Frontier Co is 2934.T. The ticker symbol is used to trade J Frontier Co shares on the stock exchange.

Fair ValueTerminal
1,643.40 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
87.20 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website jfrontier.jp
Country
Currency
JPY
Initial public offering
Aug 27, 2021
ISIN
JP3386650000
Cusip
J28185106
Market capitalization
10.55 B JPYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2027
1.04
P/Ee 2028
0.57
P/S
P/Se
0.15
EV/EBIT
44.20
P/B Ratio
8.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.92 %
Last updated Oct 10, 2026, 6:15 PM

J Frontier Co Peer Group

J Frontier Co FIGI

2934:JP · BBG011WWK6Y72934:JT · BBG011WWM7H22934:JJ · BBG011WWM7S02934:JE · BBG011WWM7W52934:JI · BBG011WWM7X42934:JU · BBG011WWM7Y32934:JW · BBG011WWM7Z22934:JV · BBG0193RDSW5R0L:GR · BBG01JPJ4CV3R0L:GF · BBG01JPJ4CW22934EUR:EO · BBG01JPW1K852934EUR:X2 · BBG01JPW1KY6